Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer

Head Neck. 2014 May;36(5):611-6. doi: 10.1002/hed.23342. Epub 2013 Jul 2.

Abstract

Background: This study compared the risk of fatal cerebrovascular accidents (CVAs) in patients with early-stage glottic laryngeal cancer receiving surgery or external beam radiation therapy (EBRT).

Methods: Using a competing risks survival analysis, we compared the risk of death because of CVA among patients with early-stage glottic laryngeal cancer receiving surgery or EBRT in the Surveillance, Epidemiology, and End Results (SEER) database.

Results: The cumulative incidence of fatal CVA at 15 years was higher in patients receiving EBRT (2.8%; 95% confidence interval [CI], 2.3% to 3.4%) compared to surgery (1.5%; 95% CI, 0.8% to 2.3%; p = .024). In multivariable competing risks regression models, EBRT remained associated with an increased risk of fatal CVA compared to surgery (adjusted hazard ratio [HR], 1.75; 95% CI, 1.04-2.96; p = .037).

Conclusion: Treatment for early-stage glottic laryngeal cancer with EBRT was associated with a small increase in the risk of late fatal CVA events relative to surgery.

Keywords: cerebrovascular accidents; laryngeal cancer; radiation therapy.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Cause of Death
  • Confidence Intervals
  • Disease-Free Survival
  • Early Detection of Cancer
  • Female
  • Follow-Up Studies
  • Glottis / pathology
  • Humans
  • Laryngeal Neoplasms / mortality*
  • Laryngeal Neoplasms / pathology
  • Laryngeal Neoplasms / radiotherapy*
  • Laryngeal Neoplasms / surgery
  • Laryngectomy / adverse effects*
  • Laryngectomy / methods
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Proportional Hazards Models
  • Radiotherapy, High-Energy / adverse effects*
  • Radiotherapy, High-Energy / methods
  • Registries
  • Regression Analysis
  • Retrospective Studies
  • Risk Assessment
  • SEER Program
  • Stroke / etiology*
  • Stroke / mortality*
  • Stroke / physiopathology
  • Survival Rate
  • Treatment Outcome